NCT06636786: Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)
- State
- Under way
- Phase
- Phase 2
- People
- 180 planned
- Started
- 25 Mar 2025
- Primary completion
- Nov 2026
- Arms
- Cyclobenzaprine HCl
- Results
- None posted
- 15 Oct 2024: Trial registered
- 25 Mar 2025: Trial started